AbCellera Biologics Inc (ABCL) Stock Price Today
Key Stats
- $2.12BMarket Cap
- -Volume
- HealthSector
- $9.3452W High
- $2.7852W Low
- -Typical Hold Time
- $1.71BEnterprise Value
- -Div Yield
- -Trading Activity
Track AbCellera Biologics Inc (ABCL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbCellera Biologics Inc has traded between a low of $2.78 and a high of $9.35, highlighting its annual price range. Buy and sell AbCellera Biologics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Most Recent News
Oil prices rise as hopes for U.S.-Iran peace deal fade, WTI eyes $92-$100, Brent targets $100.
Oil prices climbed near one-week highs due to fading optimism about a U.S.-Iran peace deal, which has increased market uncertainty and risk premiums. WTI crude is approaching $82 with potential to reach $92 and $100 if key resistance levels break, wh...
Aon remains strong but overvalued with limited growth and low dividends, rated HOLD near $300/share.
Aon Plc, a leading insurance broker, is fundamentally strong but currently overvalued with a high price-to-earnings ratio of 19-22x. Its modest organic growth of around 5% and a dividend yield below 1% do not justify the premium valuation. Recent res...
Stocks surge on major acquisition deals and strong Q2 results for Aligos Therapeutics
Shares of Bowman Consulting, Varex Imaging, and MarineMax jumped significantly after each announced all-cash acquisition agreements valued between $1 billion and $1.5 billion. Bowman Consulting agreed to be acquired by Bernhard Capital Partners for $...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.